Category Archives: Campaign for Affordable Trastuzumab

Competition Commission of India pulls up Roche for anti-competitive practices

By Jyotsna Singh, Scroll | April 27, 2017 In a landmark order, the commission has initiated an investigation into the multinational pharmaceutical company’s activities. The Competition Commission of India has initiated an investigation into Swiss pharmaceutical giant Roche for unfair … Continue reading

Posted in Biologics/Biosimilars, Campaign for Affordable Trastuzumab, Cancer, Uncategorized | Tagged , , , | Leave a comment

CCI to investigate Swiss drugmaker Roche over breast cancer biosimilar

By Divya Rajagopal, The Economic Times | April 26, 2017 MUMBAI: The Competition Commission of India (CCI) will investigate Swiss drugmaker Roche over alleged attempts to block competitors from selling breast cancer drug Trastuzumab. The investigation has to be completed … Continue reading

Posted in Biologics/Biosimilars, Campaign for Affordable Trastuzumab, Cancer, Uncategorized | Tagged , , , , | Leave a comment

Indian competition commission issues a path breaking order on abuse of dominant position in pharmaceuticals

Rules Roche’s practices prima facie appear to be aimed at blocking affordable biosimilar trastuzumab – a cancer drug – in India In July 2016, Mylan Pharmaceuticals and Biocon Limited approached the Competition Commission of India regarding Roche’s anti-competitive conduct to … Continue reading

Posted in Anti competition, Biologics/Biosimilars, Campaign for Affordable Trastuzumab, Cancer | Tagged , , , , , | Leave a comment

Breastcancer doesn’t discriminate. Neither should medicine prices

Picture Courtesy: TAC Twitter

Posted in Campaign for Affordable Trastuzumab, Cancer, Drug prices, Uncategorized | Tagged | Leave a comment

Update on Letter to Chief Justice of India by Campaign for Affordable Trastuzumab

Subsequent to the letter to Chief Justice of India by Campaign for Affordable Trastuzumab stating concerns regarding IP Owners Association (IPOA) with India judiciary ,  we have heard from the credible sources that IPOA’s meeting with IPAB and Delhi High Court … Continue reading

Posted in Campaign for Affordable Trastuzumab, Conflict of Interest | Leave a comment

Experts raise concern on DIPP’s international conference on IP Law and Enforcement

Source: Pharmabiz November 15,2014 Even as the Department of Industrial Policy & Promotion (DIPP) of the Union Commerce Ministry is organsing an international conference on IP Law and Enforcement next week, experts in the field have raised concerns on IP … Continue reading

Posted in Campaign for Affordable Trastuzumab, Conflict of Interest, IPR Enforcement, Patent infringement, Patent Injunction | Leave a comment

Alarm rings on drug patent meetings

Source: The Telegraph New Delhi, Nov. 15: An Indian consortium of health activists has expressed concern that an American organisation representing large pharmaceutical corporations plans to meet Indian patent controllers and visit the Supreme Court and Delhi High Court next … Continue reading

Posted in Campaign for Affordable Trastuzumab, Conflict of Interest, IPR Enforcement, Patent infringement, Patent Injunction | Leave a comment